+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analysis of Western European Molecular Imaging Market, Forecast to 2022

  • Report

  • 125 Pages
  • August 2018
  • Region: Europe
  • Frost & Sullivan
  • ID: 4606349

Improvements in Quantitation, New Clinical Applications, and Rising Prevalance of Cancer Keeps Market on the Upward Growth Curve

This study takes a look at the Western European molecular imaging industry. The geographic scope of the market includes the United Kingdom, Germany, Italy, Spain, France, Scandinavia, and Benelux. The market is expected to experience a compound annual growth rate (CAGR) of 4.5 percent during 2017 to 2022, primarily driven by the growing incidence of cancer - with breast cancer and lung cancer being the most common cancers - and the continuing shift from single modalities to hybrid imaging. France, Germany, and Italy are hotspots for immediate future, followed by the steadily growing markets of Spain, Scandinavia, and Benelux.

Apart from the rising incidence of cancer, the greater availability of novel radiotracers and higher quantitation will drive the molecular imaging market. On the other hand, the price sensitivity of purchasers due to insufficient reimbursement and competition from other imaging modalities will continue to restrain growth.

France is the fastest growing market in Western Europe due to its high gross domestic product (GDP) spending on oncology screening programs. Italy and Germany are expected to be the second and third fastest due to the high incidence of cancer and increasing government initiatives. Spain, Benelux, and Scandinavia are forecast to grow steadily, while the United Kingdom is likely to be the slowest due to budgetary constraints.

There has been greater focus on PET/CT systems over SPECT/CT over the last few years and this trend will continue in the forecast period. Top market participants are anticipated to continue placing greater emphasis on premium modalities.

The PET/CT segment will experience the highest growth, while more stable growth is expected for the SPECT/CT segment. The latter segment has shrunken due to past shortages of Tc-99m, concerns over stability of future supply, improvements in PET MPI, and lower quantitation accuracy than PET. However, over the last few years, improvements in its technology and quantitation accuracy is expected to drive growth.

SPECT/CT has traditionally been used for cardiac imaging, while PET/CT has primarily been used for oncology imaging. This is set to change as advancements in PET/CT and SPECT/CT technologies, coupled with the launch of novel radiopharmaceuticals, will see molecular imaging applied across new clinical areas such as orthopedics and neurology.

Table of Contents

1. Executive Summary
  • Key Findings
  • Scope of the Study-Molecular Imaging
  • Key Questions this Study will Answer
  • Market Engineering Measurements-Total Molecular Imaging Market
  • Market Engineering Measurements-PET/CT
  • Market Engineering Measurements-SPECT/CT
  • Market Engineering Measurements-SPECT
  • CEO’s Perspective
  • Executive Summary-3 Big Predictions


2. Scope of the Study
  • Scope of this Study
  • Molecular Imaging-Definition


3. Market Drivers and Restraints
  • Market Drivers
  • Drivers Explained
  • Market Restraints
  • Restraints Explained


4. Forecast and Trends - Total Molecular Imaging Market
  • Market Engineering Measurements
  • Forecast Assumptions
  • Unit Shipment Forecast
  • Total Molecular Imaging Market Revenue Forecast
  • Revenue Forecast by Segment
  • Forecast Discussion
  • Percent Revenue Forecast by Country
  • Revenue Forecast by Country
  • Forecast Discussion


5. Top Global Molecular Imaging Market Trends
  • Shift in Focus from Standalone to Hybrid Imaging
  • Role of Molecular Imaging in Personalized Medicine
  • PET Scanning and Alzheimer’s Disease


6. Growth Opportunities and Companies to Action
  • 5 Major Growth Opportunities
  • Strategic Imperatives for Success and Growth


7. PET/CT Equipment Segment
  • Market Engineering Measurements
  • Unit Shipment Forecast
  • Revenue Forecast
  • Forecast Discussion
  • Market Share
  • Market Share Analysis


8. SPECT/CT Equipment Segment
  • Market Engineering Measurements
  • Unit Shipment Forecast
  • Revenue Forecast
  • Forecast Discussion
  • Market Share
  • Market Share Analysis


9. SPECT Equipment Segment
  • Market Engineering Measurements
  • Unit Shipment Forecast
  • Revenue Forecast
  • Forecast Discussion
  • Market Share
  • Market Share Analysis


10. Germany Breakdown
  • Germany Market Analysis
  • Unit Shipment Forecast
  • Revenue Forecast
  • Segment Revenue Forecast
  • Forecast Discussion


11. United Kingdom Breakdown
  • United Kingdom Market Analysis
  • Unit Shipment Forecast
  • Revenue Forecast
  • Revenue Forecast by Segment
  • Forecast Discussion


12. France Breakdown
  • France Market Analysis
  • Unit Shipment Forecast
  • Revenue Forecast
  • Segment Revenue Forecast
  • Forecast Discussion


13. Spain Breakdown
  • Spain Market Analysis
  • Unit Shipment Forecast
  • Revenue Forecast
  • Segment Revenue Forecast
  • Forecast Discussion


14. Italy Breakdown
  • Italy Market Analysis
  • Unit Shipment Forecast
  • Revenue Forecast
  • Segment Revenue Forecast
  • Forecast Discussion


15. Scandinavia Breakdown
  • Scandinavia Market Analysis
  • Unit Shipment Forecast
  • Revenue Forecast
  • Segment Revenue Forecast
  • Forecast Discussion


16. Benelux Breakdown
  • Benelux Market Analysis
  • Unit Shipment Forecast
  • Revenue Forecast
  • Segment Revenue Forecast
  • Forecast Discussion


17. The Last Word
  • The Last Word-3 Big Predictions
  • The Last Word-Discussion
  • Legal Disclaimer


18. Appendix
  • Market Engineering Methodology
  • Installed Base of PET and PET/CT in Total Europe
  • Density of PET and PET/CT in Western Europe
  • List of Exhibits

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Digirad
  • GE Healthcare
  • Heatlhineers
  • Neusoft
  • Philips Healthcare
  • Siemens
  • Spectrum Dynamics
  • Toshiba